FDA Inspection 1320528 — Mathilde Cailliez, M.D.
The FDA completed an inspection of Mathilde Cailliez, M.D. on Jun 5, 2026 in Marseille 5e Arrondissement. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 5, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Marseille 5e Arrondissement (France)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7230 | 21 CFR 50.27(b)(2) | Short form: Oral presentation/signing |